Metabolizing Enzymes: An Introduction and Background (Dav E. Moody) PPsI are a group of ‘ructura1ly diverse compounds that pro-duce similar changes in experimental animals. These responses occur primarily in hepatocytes and include enlargement of th
AbstractDietary treatment of male C57B1/6 mice with clolibrate, nafenopin or WY-14.643 resulted in a...
LY171883 was shown to increase the incidence of hepatocel-lular carcinomas and other proliferative l...
Peroxisome proliferators constitute a novel class of non-mutagenic hepatocarcinogens, all of which i...
Peroxisome proliferators (PPs) cause proliferation of peroxisomes and hepatocarcinogenesis in rodent...
Peroxisome proliferators constitute an important group of xenobiotics with therapeutic, societal, an...
Peroxisome proliferators are a diverse group of chemicals that include several therapeutically used ...
Certain lipid-regulating agents induce hepatomegaly, hepatic peroxisome proliferation and hepatocarc...
Induction of drug-metabolizing enzymes (DMEs) is highly species-specific and can lead to drug-drug i...
Peroxisome proliferators are structurally diverse compounds that include industrial chemicals, envir...
1. Species differences in elements of the peroxisome proliferator domain (PPD), including the cytoch...
International audiencePeroxisome proliferators (PPs) are a class of rodent nongenotoxic hepatocarcin...
The purpose of the workshop "Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard ...
Peroxisomes are essential organelles for normal cell functions in all organisms from yeast to human....
The mechanism of induction of peroxisome proliferation by xenobiotics was investigated. Firstly, the...
The absence of a genotoxic action in the rat of several peroxisome proliferators (PP) has been confi...
AbstractDietary treatment of male C57B1/6 mice with clolibrate, nafenopin or WY-14.643 resulted in a...
LY171883 was shown to increase the incidence of hepatocel-lular carcinomas and other proliferative l...
Peroxisome proliferators constitute a novel class of non-mutagenic hepatocarcinogens, all of which i...
Peroxisome proliferators (PPs) cause proliferation of peroxisomes and hepatocarcinogenesis in rodent...
Peroxisome proliferators constitute an important group of xenobiotics with therapeutic, societal, an...
Peroxisome proliferators are a diverse group of chemicals that include several therapeutically used ...
Certain lipid-regulating agents induce hepatomegaly, hepatic peroxisome proliferation and hepatocarc...
Induction of drug-metabolizing enzymes (DMEs) is highly species-specific and can lead to drug-drug i...
Peroxisome proliferators are structurally diverse compounds that include industrial chemicals, envir...
1. Species differences in elements of the peroxisome proliferator domain (PPD), including the cytoch...
International audiencePeroxisome proliferators (PPs) are a class of rodent nongenotoxic hepatocarcin...
The purpose of the workshop "Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard ...
Peroxisomes are essential organelles for normal cell functions in all organisms from yeast to human....
The mechanism of induction of peroxisome proliferation by xenobiotics was investigated. Firstly, the...
The absence of a genotoxic action in the rat of several peroxisome proliferators (PP) has been confi...
AbstractDietary treatment of male C57B1/6 mice with clolibrate, nafenopin or WY-14.643 resulted in a...
LY171883 was shown to increase the incidence of hepatocel-lular carcinomas and other proliferative l...
Peroxisome proliferators constitute a novel class of non-mutagenic hepatocarcinogens, all of which i...